International collaboration drugs

International Collaboration The focus has been on promoting international cooperation directed at assuring drug product quahty and consistency of cGMPs. 

Baker JT, Borris RP, Carte B, Cordell GA, Soejarto DD, Cragg GM, Gnpta MP, Iwu MM, MaduUd DR, Tyler VE. (1995) Natural products drug discovery and development New perspectives on international collaboration. J Nat Prod 5% 1325-1357. 

The participants of the WHO international Conference Combating Counterfeit Drugs Building Effective International Collaboration, gathered in Rome on 18 February 2006... 

But, regulatory agencies also need to be on guard. We are aware that drug development is a global enterprise, and we live in a small world, and thus international collaboration between regulatory agencies and other private... 

A report was given on the activities being undertaken to combat counterfeit drugs. Strong efforts were being made to promote the concept of improved international collaboration (e.g. a framework convention) in national and international forums, and negotiations to obtain funding and support for an international conference. The conference is planned to be held in Rome in February 2006. 

The NCI (National Cancer Institute, USA) experience in international collaboration in drug discovery and development 99PAC1619. 

Paul F Long is a molecular microbiologist whose research sits at the interface of chemistry, biology and clinical pharmaceutics. He has worked in natural product drug discovery in both the health service and pharmaceutical industry, as well as more recently in academia with international collaborations spanning Europe, Japan, the USA and Australia. His interests extend to applying pharmacogenomics to problems in paediatric clinical pharmacy from the use of natural product-derived therapeutics. 

Suzuki A, Andrade RJ, Bjomsson E, Lucena MI, Lee, WM, Yuen, NA, Hunt, CM, Freston, JW (2010) Drugs associated with hep-atotoxicity and theh reporting frequency of liver adverse events in VigiBase unified list based on international collaborative work. Drug Saf i i, 503-22. 

Collaborative drug discovery projects in the public domain normally focus on neglected tropical diseases (e.g., tuberculosis, malaria, and leishmaniasis) due to the evident medical need, the reduced competition, and associated intellectual property burden. The Medicines for Malaria Venture (MMV) [32] was the first to focus on malaria in a collaborative shion. MMV started in 1999 with initial funding (US 4 million) from the governments of Switzerland and the Netherlands, the UK Department for International Development, the World Bank, and the Rockefeller Foundation. 

Cragg, G.M. and Newman, D.J. (2005) International collaboration in drug discovery and development from natural sources. Pure Appl. Ghent. 77, 1923 1942... 

In 1999, the first collaborative attempt to study the prescribing of psychotropic drugs in several East Asian countries was initiated. The preliminary international... 

The programme consists of a network of the national centres, WHO headquarters, Geneva and the WHO Collaborating Centre for International Drug Monitoring, the Uppsala Monitoring Centre, in Uppsala, Sweden. As of July 2008, 84 countries had joined the programme, and in addition, 33 countries were considered associate members. 

---